🇺🇸 FDA
Pipeline program

Ga-68-PSMA-11

2031231

Phase 3 small_molecule terminated

Quick answer

Ga-68-PSMA-11 for Prostate Cancer is a Phase 3 program (small_molecule) at Telix Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Telix Pharmaceuticals Ltd
Indication
Prostate Cancer
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials